Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Ströhle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, Rück C; the DCS Anxiety Consortium; Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P. Mataix-Cols D, et al. Among authors: gutner c. JAMA Psychiatry. 2017 May 1;74(5):501-510. doi: 10.1001/jamapsychiatry.2016.3955. JAMA Psychiatry. 2017. PMID: 28122091 Review.
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, de la Cruz LF, Andersson E, Rück C, Monzani B, Pérez-Vigil A, Frumento P, Davis M, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Storch EA, Ströhle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner CA, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P, Turner C, Otto MW. Rosenfield D, et al. Among authors: gutner ca. J Anxiety Disord. 2019 Dec;68:102149. doi: 10.1016/j.janxdis.2019.102149. Epub 2019 Sep 23. J Anxiety Disord. 2019. PMID: 31698111 Free PMC article.
Cognitive enhancers for anxiety disorders.
Hofmann SG, Smits JA, Asnaani A, Gutner CA, Otto MW. Hofmann SG, et al. Pharmacol Biochem Behav. 2011 Aug;99(2):275-84. doi: 10.1016/j.pbb.2010.11.020. Epub 2010 Dec 4. Pharmacol Biochem Behav. 2011. PMID: 21134394 Free PMC article. Review.
Linguistic correlates of social anxiety disorder.
Hofmann SG, Moore PM, Gutner C, Weeks JW. Hofmann SG, et al. Among authors: gutner c. Cogn Emot. 2012;26(4):720-6. doi: 10.1080/02699931.2011.602048. Epub 2011 Aug 18. Cogn Emot. 2012. PMID: 21851248 Free PMC article.
Cortisol, stress, and attentional bias toward threat.
McHugh RK, Behar E, Gutner CA, Geem D, Otto MW. McHugh RK, et al. Anxiety Stress Coping. 2010 Oct;23(5):529-45. doi: 10.1080/10615801003596969. Anxiety Stress Coping. 2010. PMID: 20191400
45 results